NXTC

Conviction 8HealthcareScan · Thu, Jun 25, 2026

NXTC$1.68-5.08%

ResistanceSupportVol 14

Vol MA14 145.88K

Mar 26Apr 14May 1May 19Jun 8Jun 25

NextCure, Inc.PHARMACEUTICAL PREPARATIONSwww.nextcure.com ↗

Price1.68

Change-5.08%

Gap-3.95%

Rel volume0.65×

Avg volume173.84K

Avg $ vol463K

SMA 202.77

SMA 507.02

SMA 2009.76

Price vs 50-76.05%

Price vs 200-82.78%

MA stackbearish

50/200 cross—

Supertrenddown · 3.18

RSI (14)21

MACD hist0.16

MACD crossbull · 4d

Stoch %K / %D5 / 7

ADX (14)45

+DI / −DI9 / 36

RSI divergence—

MACD divergence—

ATR %+36.48%

ADR %19.92%

52w high14.27

52w low0.3950

From 52w high-88.23%

Above 52w low+325.32%

New 52w highNo

SqueezeOff

Bollinger width186.96%

%B0.29

Donchian pos1.49%

Donchian high6.96

Donchian low1.60

AVWAP (52w high)8.39

vs AVWAP high-79.98%

AVWAP (52w low)7.34

vs AVWAP low-77.13%

OBV trendDown

Chaikin MF (20)-0.44

Today vs 20d0.65×

Avg vol (14d)145.88K

Avg vol (20d)173.84K

Avg $ vol (20d)463K

Market cap6.07M

RS 3m (vs SPY)-94.45%

RS 6m (vs SPY)-92.18%

RS line new highNo

Trend template2/8

Technical rank1.6

1 week-23.64%

1 month-76.07%

3 months-83.51%

6 months-85.47%

1 year+260.75%

YTD-87.35%

P/E-0.11

P/B0.23

P/S0.27

P/FCF-0.12

EPS-19.65

Div yield—

ROE-209.03%

ROA-147.05%

Debt/Eq0.10

Current4.61

EV/EBITDA0.12

Gross margin—

Net margin-249.55%

Rev growth0.00%

EPS growth-0.34%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-6.46M

Revenue22.38M

Net income-9.8M

Gross profit—

Free cash flow-50.09M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out3.61M

Employees40

ListedThu, May 9, 2019

Free float2.51M

Float %69.7%

Short interest68.69K

Days to cover1.4d

Short volume44.0%

Squeeze score15 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$2.03 · 1 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction8 / 100

Pattern quality—

Tech rank1.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance11.01

Support2.31

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NXTC

All disclosures →

No recent disclosed trades by Congress in NXTC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NXTC · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Borgman Anne Elizabeth Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
Houston John G Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
Webster Stephen W Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
Feigal Ellen Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
Jones Elaine V Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
KABAKOFF DAVID S Director · Stock Option (Right to Buy) · 2026-06-18	Grant	3.51K	—	2026-06-18	2026-06-22

SEC filings

EDGAR filings in NXTC · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.